Longeveron (LGVN) Assets Average (2023 - 2026)
Longeveron (LGVN) posted quarterly Assets Average of $15.7 million for Q1 2026, down 32.18% year-over-year from $23.2 million in Q1 2025, and up 21.9% quarter-over-quarter from $12.9 million in Q4 2025.
Longeveron (LGVN) Assets Average (2023 - 2026) Analysis & Trends
Longeveron's Assets Average history runs 4 years deep, the most recent figure standing at $15.7 million for Q1 2026.
- In Q1 2026, Assets Average fell 32.18% year-over-year to $15.7 million; the TTM figure through Mar 2026 stood at $15.7 million (down 32.18% YoY), while the FY2025 annual figure was $17.9 million, down 4.83% from the prior year.
- Assets Average for Q1 2026 stood at $15.7 million, up from $12.9 million in the prior quarter.
- The five-year high for Assets Average was $27.7 million in Q4 2024, with the low at $10.9 million in Q1 2024.
- The 4-year median for Assets Average is $16.2 million (2025), against an average of $18.1 million.
- Peak annual rise in Assets Average reached 134.01% in 2024, while the deepest fall reached 55.76% in 2024.
- Longeveron's Assets Average stood at $11.9 million in 2023, then surged by 134.01% to $27.7 million in 2024, then plunged by 53.45% to $12.9 million in 2025, then rose by 21.9% to $15.7 million in 2026.
- Business Quant data shows LGVN's Assets Average at $15.7 million in Q1 2026, $12.9 million in Q4 2025, and $16.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Longeveron | 26.51 Mn | 16.41 Mn | 182,000.00 | 18.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.35 Mn |
| Mar 31, 2026 | 15.74 Mn |
| Dec 31, 2025 | 12.91 Mn |
| Sep 30, 2025 | 16.15 Mn |
| Jun 30, 2025 | 18.80 Mn |
| Mar 31, 2025 | 23.20 Mn |
| Dec 31, 2024 | 27.73 Mn |
| Sep 30, 2024 | 24.65 Mn |
| Jun 30, 2024 | 14.55 Mn |
| Mar 31, 2024 | 10.89 Mn |
| Dec 31, 2023 | 11.85 Mn |
| Sep 30, 2023 | 14.36 Mn |
| Jun 30, 2023 | 19.45 Mn |
| Mar 31, 2023 | 24.61 Mn |